Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Televantou, D"'
Autor:
Newman, AM, Zaka, M, Zhou, P, Blain, AE, Erhorn, A, Barnard, A, Crossland, RE, Wilkinson, S, Enshaei, A, De Zordi, J, Harding, F, Taj, M, Wood, KM, Televantou, D, Turner, SD, Burke, GAA, Harrison, CJ, Bomken, S, Bacon, CM, Rand, V
Funder: RCUK | Medical Research Council (MRC); doi: https://doi.org/10.13039/501100000265
Funder: Good Will Cause
Funder: MRC/EPSRC Newcastle Pathology Node
Funder: Newcastle upon Tyne Hospitals NHS Foundation Trust (Newcastle upon Tyn
Funder: Good Will Cause
Funder: MRC/EPSRC Newcastle Pathology Node
Funder: Newcastle upon Tyne Hospitals NHS Foundation Trust (Newcastle upon Tyn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c283a72e529653e8d35fef38fe549ba2
https://www.repository.cam.ac.uk/handle/1810/334510
https://www.repository.cam.ac.uk/handle/1810/334510
Background/Aim: KRAS mutations are reported in 20-25% of non-small cell lung cancer (NSCLC) and their prognostic role is unclear. We studied KRAS and EGFR genotyping in Greek NSCLC patients. Patients and Methods: KRAS and EGFR genotypes were centrall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b4b7b7f493bc586a7db1b616bc3fe01c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078115
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078115
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Linardou, H., Kotoula, V., Kouvatseas, G., Karavasilis, V., Mountzios, G., Samantas, E., Kalogera-Fountzila, A., Televantou, D., Papadopoulou, K., Mavropoulou, X., Daskalaki, E., Zaramboukas, T., Efstratiou, I., Lambaki, S., Rallis, G., Res, E., Syrigos, K., Kosmidis, P., Pectasides, D., Fountzilas, G.
Publikováno v:
In Journal of Thoracic Oncology October 2018 13(10) Supplement:S890-S890
Autor:
Pentheroudakis, George, Kotoula, V., Roock, W. De, Kouvatseas, G., Papakostas, P., Makatsoris, T., Papamichael, D., Xanthakis, I., Sgouros, J., Televantou, D., Kafiri, G., Tsamandas, A. C., Razi, E. D., Galani, E., Bafaloukos, Dimitrios, Efstratiou, I., Bompolaki, I., Pectasides, Dimitrios, Pavlidis, Nicholas, Tejpar, S., Fountzilas, George
Publikováno v:
BMC Cancer
Background: More than half of patients with KRAS-wild type advanced colorectal cancer (CRC) fail anti-EGFR monoclonal antibodies. We studied EGFR-axis messenger RNA (mRNA) expression and RAS, RAF, PIK3CA mutations in order to identify additional biom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0106125f1185a01968e3202a90432d90
https://doi.org/10.1186/1471-2407-13-49
https://doi.org/10.1186/1471-2407-13-49
Background: The HER2 gene has been established as a valid biological marker for the treatment of breast cancer patients with trastuzumab and probably other agents, such as paclitaxel and anthracyclines. The TOP2A gene has been associated with respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::24ddb2fb5e80a59c6d81de33172df082
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3087993
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3087993
Autor:
Razi, E. D., Kalogeras, K. T., Kotoula, V., Eleftheraki, A. G., Nikitas, N., Kronenwett, R., Timotheadou, E., Christodoulou, C., Pectasides, Dimitrios, Gogas, H., Wirtz, R. M., Makatsoris, T., Bafaloukos, Dimitrios, Aravantinos, Gerasimos, Televantou, D., Pavlidis, Nicholas, Fountzilas, George
Publikováno v:
Clinical Breast Cancer
The CXCL13-CXCR5 is a chemokine axis that is activated in some breast cancers. A total of 321 tissue blocks from a group of patients who received adjuvant, dose-dense chemotherapy for high-risk early breast cancer were examined. Activation of this ax
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60cce7c53a2400ce20569633f393fb99
https://gnosis.library.ucy.ac.cy/handle/7/41623
https://gnosis.library.ucy.ac.cy/handle/7/41623
Background: The aim of the present study was to investigate the efficacy of adjuvant dose-dense sequential chemotherapy with epirubicin, paclitaxel, and CMF in subgroups of patients with high-risk operable breast cancer, according to tumor subtypes d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::40b5737d89f956992c28a4b74c408f75
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3057108
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3057108
Purpose: It is well recognized that breast cancer is a heterogeneous disease. The purpose of the current study was to classify patients according to the immunohistochemical phenotype of their tumors in an effort to evaluate the outcome of the respect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::d0e9dcc5ca65fc4f27801e06b52c72e5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3061543
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3061543
Background: Chemokines are important in cell migration and are thought to play a key role in metastasis. We explored the prognostic significance of C-X-C ligand-motif (CXCL) 12, CXCL13, and receptor (CXCR) 5 on disease-free survival (DFS) and overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::adde85c7117b9ce870af5c44e6495281
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089513
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089513